Growth Metrics

Kewaunee Scientific (KEQU) EPS (Weighted Average and Diluted) (2016 - 2026)

Kewaunee Scientific has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.23 for Q1 2026.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.23 for Q1 2026, down 48.89% from a year ago — trailing twelve months through Jan 2026 was $3.72 (down 37.37% YoY), and the annual figure for FY2025 was $3.83, down 39.97%.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.23 at Kewaunee Scientific, down from $0.82 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for KEQU hit a ceiling of $3.74 in Q2 2024 and a floor of -$0.47 in Q1 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.74 (2024), compared with a mean of $0.7.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 1666.67% in 2022 and later soared 1133.33% in 2023.
  • Kewaunee Scientific's EPS (Weighted Average and Diluted) stood at -$0.09 in 2022, then soared by 1133.33% to $0.93 in 2023, then grew by 8.6% to $1.01 in 2024, then fell by 18.81% to $0.82 in 2025, then crashed by 71.95% to $0.23 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.23 (Q1 2026), $0.82 (Q4 2025), and $1.04 (Q3 2025) per Business Quant data.